Apremilast
Products Apremilast is commercially available in the form of film-coated tablets (Otezla). It was approved in the United States in 2014 and in many countries and the EU in 2015. Structure and properties Apremilast (C22H24N2O7S, Mr = 460.5 g/mol) is a dioxoisoindole acetamide derivative. Effects Apremilast (ATC L04AA32) has immunomodulatory and anti-inflammatory properties. The effects … Apremilast